Dopamine News and Research

Latest Dopamine News and Research

New dopamine sensors could improve our understanding of Parkinson’s Disease

Researchers have developed a sensor that can measure dopamine in the brain for more than a year. The tech could help us understand Parkinson's and depression.

12 Sep 2018

ADHD patients have increased risk of developing Parkinson's and other similar diseases

While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder, the long-term health effects of having ADHD and of common ADHD medications remains understudied.

12 Sep 2018

Tiny sensors can measure dopamine levels in the brain for more than a year

Dopamine, a signaling molecule used throughout the brain, plays a major role in regulating our mood, as well as controlling movement. Many disorders, including Parkinson's disease, depression, and schizophrenia, are linked to dopamine deficiencies.

12 Sep 2018

Mechanically ventilated patients treated with vasopressor may develop ICU-related weakness

At least 25 percent of critically ill patients who receive mechanical ventilation in intensive care units develop muscular weakness severe enough to impair their quality of life.

11 Sep 2018

Immune system that fights infection could join battle against opioid addiction

The same immune system that fights infection and the flu could join the battle against opioid addiction, new research out of the Vanderbilt Center for Addiction Research indicates.

7 Sep 2018

Immune system may join battle against opioid addiction

The same immune system that fights infection and the flu could join the battle against opioid addiction, new research out of the Vanderbilt Center for Addiction Research indicates.

6 Sep 2018

Dopamine receptor study opens door to targeted treatments for neuropsychiatric disorders

New work from researchers at Columbia University Vagelos College of Physicians and Surgeons sheds light on how dopamine receptors signal within cells, opening the door for more targeted--and more tolerable--therapeutics to treat an array of neuropsychiatric disorders.

4 Sep 2018

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.

3 Sep 2018

Bile acids reduce desire for cocaine, finds study

Bile acids -- gut compounds that aid in the digestion of dietary fats -- reduce the desire for cocaine, according to a new study by researchers at Vanderbilt University Medical Center and the University of Alabama at Birmingham.

31 Aug 2018

Modified Nurr1 protein may pave way for new Parkinson's therapy

Researchers have modified the protein Nurr1 so that it can enter cells from the outside. Nurr1 deficiency may be one of the causes of Parkinson's disease.

31 Aug 2018

Component of cannabis could help in psychosis

Researchers from King’s College London have now found how the chemical cannabidiol or CBD from cannabis can reduce the abnormal brain activity in patients who are at risk of psychosis. The study was published in the latest issue of the journal JAMA Psychiatry.

30 Aug 2018

New study supports motor cortex 'excitability' as cause of restless legs syndrome

Johns Hopkins Medicine researchers say new experiments using magnetic pulse brain stimulation on people with moderate to severe restless legs syndrome have added to evidence that the condition is due to excitability and hyperarousal in the part of the brain's motor cortex responsible for leg movement.

29 Aug 2018

Researchers create candidate drugs with potential to curb smoking

Washington State University researchers have created more than a dozen candidate drugs with the potential to curb smokers' desire for nicotine by slowing how it is broken down in the body. The researchers hope the substances can help people reduce their consumption of tobacco, if not quit altogether.

28 Aug 2018

Finding ways to improve cell replacement therapy for Parkinson's disease

Parkinson's disease is a neurodegenerative disease that affects dopamine signaling neurons in patients' brains. Cell-replacement therapy shows some promise as a treatment for Parkinson's. A recent paper in the journal Molecular & Cellular Proteomics reports a technical advance in selecting cells to use in this therapy.

24 Aug 2018

Study shows link between thinning of the retina and early sign of Parkinson's disease

The eyes may be a window to the brain for people with early Parkinson's disease. People with the disease gradually lose brain cells that produce dopamine, a substance that helps control movement.

16 Aug 2018

Study: Children who enter adolescence with weak cognitive control are at risk for trouble in adulthood

Children who struggle with weak cognitive control at an early age are at most risk for trouble in adulthood following their engagement in risk-taking activities in adolescence, according to new research.

10 Aug 2018

Scientists are one step closer to understanding autistic disorders

Autism spectrum disorders are a heterogeneous group of neurodevelopmental disorders, one of the main characteristics of which is impaired social communication.

10 Aug 2018

Study: Exercise can help prevent relapses into cocaine addiction

Exercise can help prevent relapses into cocaine addiction, according to new research led by the University at Buffalo's Panayotis (Peter) Thanos, PhD.

9 Aug 2018

Social environment influences individuality of mice

Individuality is not exclusive to humans. Though this idea was previously rebutted by biologists, today it is accepted that individuality is found in all animal species. It is defined as all the behavior differences between individuals of a single species that are relatively stable over time.

6 Aug 2018

New nuclear medicine test could improve care of patients with type 1 diabetes

Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The new positron emission tomography imaging method could measure beta-cell mass, which would greatly enhance the ability to monitor and guide diabetes therapies.

3 Aug 2018

Dopamine News and Research

Latest Dopamine News and Research

New dopamine sensors could improve our understanding of Parkinson’s Disease

ADHD patients have increased risk of developing Parkinson's and other similar diseases

Tiny sensors can measure dopamine levels in the brain for more than a year

Mechanically ventilated patients treated with vasopressor may develop ICU-related weakness

Immune system that fights infection could join battle against opioid addiction

Immune system may join battle against opioid addiction

Dopamine receptor study opens door to targeted treatments for neuropsychiatric disorders

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Bile acids reduce desire for cocaine, finds study

Modified Nurr1 protein may pave way for new Parkinson's therapy

Component of cannabis could help in psychosis

New study supports motor cortex 'excitability' as cause of restless legs syndrome

Researchers create candidate drugs with potential to curb smoking

Finding ways to improve cell replacement therapy for Parkinson's disease

Study shows link between thinning of the retina and early sign of Parkinson's disease

Study: Children who enter adolescence with weak cognitive control are at risk for trouble in adulthood

Scientists are one step closer to understanding autistic disorders

Study: Exercise can help prevent relapses into cocaine addiction

Social environment influences individuality of mice

New nuclear medicine test could improve care of patients with type 1 diabetes

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Dopamine News and Research

Latest Dopamine News and Research

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Newsletters you may be interested in